ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), announced that a leading Italian pharmaceutical company selected ValGenesis VLMS – the...
The human gut is inhabited by a plethora of micro-organisms, collectively called the "microbiota," which are important for normal physiological processes. "Dysbiosis" or an...
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced the Company will be presenting updated data from the DisTinGuish...
ImmunityBio, Inc, a clinical-stage immunotherapy company, announced interim results (N=63) in its metastatic pancreatic cancer trial (QUILT 88) showing that the overall survival rate...
Neurimmune AG announced that it has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. The collaboration is focused on creating...
